Cargando…
Decreased hepatic function in patients with hepatoma or liver metastasis monitored by a hepatocyte specific galactosylated radioligand.
99mTc-galactosylated neoglycoalbumin (99mTc-NGA) is a hepatocyte-specific tracer that, after injection into the blood stream, delivers radioactivity selectively to the liver. This is based upon chemical recognition and binding by the hepatic binding protein (HBP), a receptor specific for galactosyla...
Autores principales: | Virgolini, I., Müller, C., Klepetko, W., Angelberger, P., Bergmann, H., O'Grady, J., Sinzinger, H. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1990
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971700/ https://www.ncbi.nlm.nih.gov/pubmed/2164838 |
Ejemplares similares
-
Scintigraphic evaluation of functional hepatic mass in patients with advanced breast cancer.
por: Virgolini, I., et al.
Publicado: (1993) -
Decrease of prostaglandin I2 binding sites in thyroid cancer.
por: Virgolini, I., et al.
Publicado: (1988) -
Human hepatocellular cancers show decreased prostaglandin E1 binding capacity.
por: Virgolini, I., et al.
Publicado: (1989) -
Development of Novel Galactosylated PLGA Nanoparticles for Hepatocyte Targeting Using Molecular Modelling
por: Raposo, Cláudia D., et al.
Publicado: (2020) -
Synthesis and biological activity of α-galactosyl ceramide KRN7000 and galactosyl (α1→2) galactosyl ceramide
por: Veerapen, Natacha, et al.
Publicado: (2009)